12:30-2:00 p.m. – Ethics, Law and Unintended Consequences of AI in Health Care
Artificial intelligence and its many applications (eg., prediction, visualization, decision support) have been largely discussed in healthcare settings. As the explosion of available electronic health data continues worldwide, AI has been described as a solution (or promise) for cost reduction, quality improvement and access to care, behavior change, etc. This panel will explore potential unintended but predictable consequences of an AI future in human health, with recommendations on how to recognize and mitigate credible risks, all of which warrant an intentional process for validation and monitoring. It will discuss the implications of technological automation to improve healthcare efficiency and access to care, and how job roles may potentially exacerbate existing inequities without dedicated investments into human workforce development. The panel will touch on the legal landscape for AI-based healthcare.
Dr. Peter Embí serves as President and CEO of the Regenstrief Institute. He is also the Associate Dean for Informatics and Health Services Research at the Indiana University School of Medicine, the Associate Director at Indiana CTSI and Vice President for Learning Health Systems at IU Health. He is an internationally recognized researcher, educator, and leader in the field of clinical and translational research informatics. His areas of interest include biomedical informatics, health information technology, patient-centered outcomes and learning health systems.
Dr. Kenneth W. Goodman is founder and director of the University of Miami Miller School of Medicine’s Institute for Bioethics and Health Policy and co-director of the university’s Ethics Programs. The Institute has been designated a World Health Organization Collaborating Center in Ethics and Global Health Policy, one of ten in the world. He is a co-founder of the North American Center for Ethics and Health Information Technology, a partnership with the Center for Bioethics at Indiana University. Dr. Goodman’s research has emphasized issues in health information technology and in epidemiology and public health. He has written and edited a number of books.
Dr. Eneida Mendonca is vice president for research development at Regenstrief Institute. Her research focuses on developing novel language-driven approaches and automated learning methods to support decision making; exploiting automated semantic and statistical methods to extract biomedical data from patient records; creating new ways to automatically integrate evidence into clinical practice; and improving infrastructure for healthcare and clinical research. She has been involved in many federally funded grant projects, including a $3.9 million NIH-funded Environmental Influences on Child Health Outcomes (ECHO) study and the Children’s Respiratory Research and Environment Workgroup (CREW), where she uses informatics tools to harmonize data among several large cohorts, combining clinical data, social determinants of health, behavior and biological markers, among others.
Dr. Peter H. Schwartz is the Director of the IU Center for Bioethics and Associate Professor of Medicine at IU School of Medicine. He directs the Bioethics and Subject Advocacy Program of the Indiana Clinical and Translational Sciences Institute (CTSI) and co-leads the Behavioral Science and Ethics cluster of the IU Precision Health Initiative. He practices adult outpatient medicine in the Eskenazi Health System. Dr. Schwartz conducts research on patient decision-making and risk communication in preventive and personalized medicine. He has written widely on ethical issues in these and other areas.